Note: Ingredients listed on restricted chemical lists
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
Proprietary
EC/CAS
232-383-7/8012-89-3
Name of the chemical
beeswax
Concentration
Proprietary
EC/CAS
9005-67-8
Name of the chemical
polyethyleneglycol sorbitan monostearate
Concentration
N/A
EC/CAS
500-019-9/9005-65-6
Name of the chemical
polyethyleneglycol sorbitan monooleate
Concentration
019-9
EC/CAS
246-376-1/24634-61-5
Name of the chemical
Potassium (E,E)-hexa-2,4-dienoate
Concentration
Proprietary
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
Proprietary
EC/CAS
204-498-2/121-79-9
Name of the chemical
Propyl 3,4,5-trihydroxybenzoate
Concentration
Proprietary
EC/CAS
203-768-7/110-44-1
Name of the chemical
Hexa-2,4-dienoic acid
Concentration
Proprietary
EC/CAS
200-313-4/57-11-4
Name of the chemical
stearic acid
Concentration
Proprietary
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
Proprietary
General Information
Revision date
2013-08-31
Product name
DESONIDE CREAM
Product Synonyms
NDC 00472-0804-15 0.05% 15 gram; NDC 00472-0804-60 0.05% 60 gram
supplier name
U.S
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
ACTAVIS, INC
e-mail address of the competent person responsible for the Safety Data Sheet
SDS@Actavis.com
Section 2
SECTION 2: Hazards identification
Product definition
This product is a white to off-white cream supplied in tubes
Health hazards
The chief health hazard associated with overexposures during normal use and handling is the potential for irritation of contaminated skin. In therapeutic use, the most common adverse effects reported include stinging and burning, irritation, contact dermatitis, condition worsened, peeling of skin, itching, intense transient swelling, and dryness/scaliness, and application site reactions. Other adverse skin effects can occur, as well as adverse effects on the adrenal system and changes in blood chemistry. May cause fetal harm in pregnancy, based on information for corticosteroids as a group. Allergic contact dermatitis with corticosteroids can occur and is usually determined by failure to heal. Refer to Section 11 (Toxicological Information) for more information on potential health effects from therapeutic use. Reactivity Hazards: This product is not reactive. Flammability Hazards: This product may be combustible and ignite if exposure to high temperature or direct flame for a prolonged period. When involved in a fire, this material may decompose and produce irritating vapors and toxic compounds (including carbon oxides, nitrogen oxides).
Environmental hazards
Large quantities released to the aquatic and terrestrial environment may have an adverse effect. Emergency Considerations: Emergency responders should wear appropriate protection for situation to which they respond.